EP3412290
ANDRÓGEN VIÐTAKABEINIR TIL MEÐFERÐAR VIÐ KRABBAMEINI Í BLÖÐRUHÁLSKIRTLI OG SJÚKDÓMAR SEM TENGJAST ANDRÓGEN VIÐTÖKUM.
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.3.2007EP published:
3.3.2021EP application number:
18181743.8
EP translation filed:
12.4.2021Grant published:
15.6.2021EPO information:
European Patent Register
Max expiry date:
26.3.2027Expiry date:
26.3.2027
Title:
ANDROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND ANDROGEN RECEPTOR-ASSOCIATED DISEASES
Timeline
Today
27.3.2007EP application
3.3.2021EP Publication
12.4.2021Translation submitted
15.6.2021Registration published
26.3.2027Expires
Owner
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, Oakland, CA 94607, US
Inventor
Name:
JUNG, Michael EAddress:
Los Angeles, CA 90095-1569, US
Name:
SAWYERS, Charles LAddress:
New York, NY 10021, US
Name:
OUK, SamedyAddress:
Los Angeles, CA 90095-1569, US
Name:
TRAN, ChrisAddress:
New York, NY 10021, US
Name:
WONGVIPAT, JohnAddress:
New York, NY 10021, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
78597806 PDate:
27.3.2006Country:
US
Number:
83379006 PDate:
28.7.2006Country:
US
Classification
Categories:
A61K 31/4166, A61K 31/4178, A61K 31/4439, C07D 233/86, C07D 401/04
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 6.4.2021
Expires: 26.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 2.3.2022
Expires: 26.3.2023
Payer: Patice ehf.
Number: 17
Paid: 9.3.2023
Expires: 26.3.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 6.3.2024
Expires: 26.3.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 13.2.2025
Expires: 26.3.2026
Payer: Árnason Faktor ehf.
Number: 20
Paid: 27.3.2026
Expires: 26.3.2027
Payer: Árnason Faktor ehf.